Your Cart is Empty
There is no single topical tranexamic-acid percentage proven best for every skin concern or formulation. Research includes products around 2% to 5%, with some higher-strength comparisons, but the number alone cannot tell you delivery, tolerance or visible performance.
Use the TXA overview for its general role. This guide addresses the narrower question of how to interpret concentration when reading a study or choosing a formula.
| Percentage | Example of research context | Interpretation |
|---|---|---|
| 2% | Tested alongside niacinamide in a pigmentation cream | Evidence for a combination, not TXA’s isolated contribution |
| 2% or 3% | Included in multi-ingredient serums studied on arm skin | Not direct proof of facial melasma performance |
| 5% | Used in several topical melasma and PIH trials | A studied strength, not a universal recommendation |
| 10% | Compared with 5% in one very small melasma trial | Limited evidence does not establish a reason to choose the higher amount |
For the combination designs, see TXA with niacinamide and TXA with alpha arbutin. Keeping those details attached to the number prevents a research concentration from becoming an unsupported shopping rule.
A 2024 randomized study compared 5% and 10% topical TXA in 16 women with epidermal melasma over eight weeks. It found no significant between-group difference in the measured outcomes. With only eight participants per group, this cannot establish equivalence or settle uncommon adverse effects.
The result offers no strong basis for assuming that doubling the percentage improves a routine. It also does not prove that 5% is ideal for everyone. Both conclusions would go beyond the experiment.
A 2025 trial compared different TXA/niacinamide creams, including a niosomal formulation, with hydroquinone. Because the carriers and ingredient amounts differed, it could not isolate the effect of TXA percentage alone.
A serum, solution and emulsion can differ in ways that a single number does not describe. The formula-selection guide covers texture, supporting ingredients and evidence for the finished product. A delivery-system claim deserves product-level support rather than automatic preference.
Check whether a front-label number refers to TXA itself or to a blend containing several ingredients. A “brightening complex” percentage is not necessarily the percentage of tranexamic acid. If the label is unclear, ask the manufacturer what the number measures.
If the exact TXA percentage is not disclosed, you cannot reliably calculate it from the product name or assume it from the position of one ingredient. Concentration transparency can make comparison easier, but a disclosed number still does not substitute for evidence.
Applying a lower-percentage product more often does not recreate a higher-percentage study. Nor can two layered products be treated as an added-up concentration. The formulation, amount applied and schedule remain different.
Use the application guide and the product’s directions. If the current formula causes irritation, increasing exposure is not a useful way to test whether the percentage is sufficient.
Start with the target: flat post-acne pigmentation, uneven tone or professionally assessed melasma. Then evaluate the exact formula, tolerance and routine fit.
For reactive skin, consult the sensitivity guide. A sensible selection is one you can assess consistently, not simply the bottle with the largest percentage printed on it.
